After GE Buy, Whatman Adds Products, Manufacturing Muscle to Slide Business

Six months after being acquired by GE Healthcare for $713 million, Whatman has developed instruments to automate its slide manufacturing and has debuted FAST Quant 40, an array-based research tool that measures the concentration of 40 different cytokines in a sample.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.